Mehta PP[au] - Search Results

Year	Number of Results
1975	1
1984	2
1986	1
1987	2
1988	2
1989	3
1990	2
1991	3
1992	5
1993	3
1995	2
1996	4
1997	4
1998	2
1999	1
2000	1
2002	1
2003	1
2004	1
2005	2
2006	1
2007	4
2008	2
2009	1
2010	4
2011	9
2012	1
2013	6
2014	7
2015	4
2016	4
2017	1
2018	3
2019	1
2020	4
2021	9
2022	0

1

Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.

Prats-Uribe A, Sena AG, Lai LYH, Ahmed WU, Alghoul H, Alser O, Alshammari TM, Areia C, Carter W, Casajust P, Dawoud D, Golozar A, Jonnagaddala J, Mehta PP, Gong M, Morales DR, Nyberg F, Posada JD, Recalde M, Roel E, Shah K, Shah NH, Schilling LM, Subbian V, Vizcaya D, Zhang L, Zhang Y, Zhu H, Liu L, Cho J, Lynch KE, Matheny ME, You SC, Rijnbeek PR, Hripcsak G, Lane JC, Burn E, Reich C, Suchard MA, Duarte-Salles T, Kostka K, Ryan PB, Prieto-Alhambra D. Prats-Uribe A, et al. Among authors: mehta pp. BMJ. 2021 May 11;373:n1038. doi: 10.1136/bmj.n1038. BMJ. 2021. PMID: 33975825 Free PMC article.

2

Retraction notice to "A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells".

Mehta PP, Kung PP, Yamazaki S, Walls M, Shen A, Nguyen L, Gehring MR, Los G, Smeal T, Yin MJ. Mehta PP, et al. Cancer Lett. 2018 May 28;422:132. doi: 10.1016/j.canlet.2018.03.019. Cancer Lett. 2018. PMID: 29579439 No abstract available.

3

An update on minding the gap in cancer.

Mesnil M, Aasen T, Boucher J, Chépied A, Cronier L, Defamie N, Kameritsch P, Laird DW, Lampe PD, Lathia JD, Leithe E, Mehta PP, Monvoisin A, Pogoda K, Sin WC, Tabernero A, Yamasaki H, Yeh ES, Dagli MLZ, Naus CC. Mesnil M, et al. Among authors: mehta pp. Biochim Biophys Acta Biomembr. 2018 Jan;1860(1):237-243. doi: 10.1016/j.bbamem.2017.06.015. Epub 2017 Jun 24. Biochim Biophys Acta Biomembr. 2018. PMID: 28655619 Free article. Review.

4

Repurposing drug molecules for new pulmonary therapeutic interventions.

Mehta PP, Dhapte-Pawar VS. Mehta PP, et al. Drug Deliv Transl Res. 2021 Oct;11(5):1829-1848. doi: 10.1007/s13346-020-00874-6. Epub 2020 Nov 13. Drug Deliv Transl Res. 2021. PMID: 33188495 Review.

5

Novel and Evolving Therapies for COVID-19 Related Pulmonary Complications.

Mehta PP, Dhapte-Pawar VS. Mehta PP, et al. Am J Med Sci. 2021 May;361(5):557-566. doi: 10.1016/j.amjms.2021.02.019. Epub 2021 Feb 25. Am J Med Sci. 2021. PMID: 33640363 Free PMC article. Review.

6

Dry powder inhalers: a concise summary of the electronic monitoring devices.

Mehta PP. Mehta PP. Ther Deliv. 2021 Jan;12(1):1-6. doi: 10.4155/tde-2020-0091. Epub 2020 Sep 1. Ther Deliv. 2021. PMID: 32873214 Free article. No abstract available.

7

Dry powder inhalers: upcoming platform technologies for formulation development.

Mehta PP. Mehta PP. Ther Deliv. 2019 Sep;10(9):551-554. doi: 10.4155/tde-2019-0062. Epub 2019 Oct 14. Ther Deliv. 2019. PMID: 31608801 Free article. No abstract available.

8

Dry powder inhalers: a brief overview of the drug detachment techniques.

Mehta PP. Mehta PP. Ther Deliv. 2020 Mar;11(3):139-143. doi: 10.4155/tde-2019-0087. Epub 2020 Jan 9. Ther Deliv. 2020. PMID: 31914863 No abstract available.

9

Introduction: a tribute to cell-to-cell channels.

Mehta PP. Mehta PP. J Membr Biol. 2007 Jun;217(1-3):5-12. doi: 10.1007/s00232-007-9068-2. Epub 2007 Sep 19. J Membr Biol. 2007. PMID: 17876494 Review. No abstract available.

10

Cysteine residues in the C-terminal tail of connexin32 regulate its trafficking.

Ray A, Mehta PP. Ray A, et al. Among authors: mehta pp. Cell Signal. 2021 Sep;85:110063. doi: 10.1016/j.cellsig.2021.110063. Epub 2021 Jun 17. Cell Signal. 2021. PMID: 34146657

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results